From Postmortem Characterization to the In Vivo Detection of Thin-Capped Fibroatheromas: The Missing Link Toward Percutaneous Treatment

Patrick W. Serruys; Héctor M. García‐García; Evelyn Regar

doi:10.1016/j.jacc.2007.04.085

Back

Related publications

Article2018

Fatigue as the missing link between bone fragility and fracture

Claire Acevedo, Vincent A. Stadelmann, Dominique P. Pioletti, Tamara Alliston, Robert O. Ritchie

Nature Biomedical Engineering

Article2016

TCT-94 Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Elvin Kedhi, Mark Kennedy, Akiko Maehara, Alexandra J. Lansky, Thomas McAndrew, Steven P. Marso, Bernard De Bruyne, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

Editorial Material2017

Percutaneous valve treatment, the younger brother of coronary angioplasty

Patrick W. Serruys

EuroIntervention

Editorial Material2015

The next step for mitral valve treatment: moving to early percutaneous intervention to prevent irreversible damage

Patrick W. Serruys

EuroIntervention

Editorial Material2016

DAPT: a historical accident in the pharmacological treatment of post-percutaneous coronary intervention

Pannipa Suwannasom, Patrick W. Serruys

EuroIntervention

From Postmortem Characterization to the In Vivo Detection of Thin-Capped Fibroatheromas: The Missing Link Toward Percutaneous Treatment

Abstract

Discussion(0)

Related publications

Fatigue as the missing link between bone fragility and fracture

TCT-94 Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Percutaneous valve treatment, the younger brother of coronary angioplasty

The next step for mitral valve treatment: moving to early percutaneous intervention to prevent irreversible damage

DAPT: a historical accident in the pharmacological treatment of post-percutaneous coronary intervention